Delivery Order SPE2DB22D2218-SPE2DB25FR2DD
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,060.03 firm fixed-price delivery order is for AMOX-CLAV 250-125 MG TABLET 30S, a generic pharmaceutical product. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,543.50 firm fixed-price delivery order is for the supply of 4565751440 AMOX-CLAV 500-125 MG TABLET 20S. The contract has a completion date of September 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,234.98 firm fixed-price delivery order is for the supply of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. Amerisourcebergen is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,745.69, is a delivery order for pharmaceutical products, including Amoxicillin-Clavulanate 1,000-62.5 mg tablets. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,668.84 delivery order contract is for the procurement of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 12, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,184.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is a delivery order valued at $2,891.52 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 40 units of Amox-Clav ER 1,000-62.5 mg tablets, a prescription medication. The contract has a firm fixed price and an ultimate completion date of January 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of AMOX-CLAV ER 1,000-62.5 MG tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $3,057.59 and an Ultimate Completion Date of July 18, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,863.65, is for the delivery of AMOX-CLAV 875-125 MG TABLET 20S, a type of antibiotic medication. The contract has a firm fixed price pricing type and a period of performance through February 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,195.52 Firm Fixed Price Delivery Order is for the supply of 100 units of AMOX-CLAV 875-125 MG TABLET, with an ultimate completion date of November 13, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...